4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-061754
President and CEO sold 5,764 shares at $3.25 ($18,733)
- President and CEO acquired 16,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chacko Jacob President and CEO | 2022-12-15 | Option exercise | +16,666 | 822,789 | D | ||
| Chacko Jacob President and CEO | 2022-12-15 | Sale | −5,764 | $3.25 | $18,733 | 817,025 | D |
| Derivatives | |||||||
| Chacko Jacob President and CEO | 2022-12-15 | Option exercise · Restricted Stock Unit | −16,666 | 33,334 | D | ||
| Open-market sales · 5,764 sh · avg $3.25 · $18,733 | |||||||
Loading xslF345X03/doc4.xml…